![]() |
市場調査レポート
商品コード
1576509
自動注射器の市場規模、シェア、予測、動向分析:タイプ、技術、用途、流通チャネル、投与経路、エンドユーザー別 - 2031年までの世界の予測Autoinjectors Market Size, Share, Forecast, & Trends Analysis by Type, Technology, Application, Distribution, Route of Administration, End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
自動注射器の市場規模、シェア、予測、動向分析:タイプ、技術、用途、流通チャネル、投与経路、エンドユーザー別 - 2031年までの世界の予測 |
出版日: 2024年09月01日
発行: Meticulous Research
ページ情報: 英文
納期: 5~7営業日
|
自動注射器市場は、2024年から2031年にかけてCAGR 8.3%で2031年までに37億6,000万米ドルに達すると予測されています。
広範な二次調査と一次調査、市場シナリオの詳細な分析を経て、当レポートは主要な市場促進要因、抑制要因、課題、機会の分析で構成されています。自動注射器市場の成長は、世界の疾病負担の増加、薬剤の自己投与への嗜好、高度な自動注射器の開発によってもたらされます。しかし、自動注射器の代替品の入手可能性、高コスト、針刺し損傷に関する懸念が市場の成長を抑制しています。
さらに、在宅医療に対する需要の高まりや、主要企業によるパートナーシップや協力関係の拡大は、市場成長の機会を生み出すと期待されています。しかし、新興国における自己注射器の使用に関する認識不足や、医療へのアクセスが限られていることは、自己注射器市場における大きな課題です。
(注:SWOT分析は上位5社について記載)
Autoinjectors Market Size, Share, Forecast, & Trends Analysis by Type (Disposable, Reusable, Wearable), Technology (Manual, Automatic), Application (Arthritis, Diabetes, Osteoporosis), Distribution, Route of Administration, End User-Global Forecast to 2031
The autoinjectors market is projected to reach $3.76 billion by 2031 at a CAGR of 8.3% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the autoinjectors market is driven by the rising disease burden globally, the preference for self-administration of drugs, and the development of advanced autoinjectors. However, the availability of alternatives to autoinjectors, their high cost, and concerns regarding needlestick injury are restraining the market's growth.
Furthermore, the rising demand for home healthcare and growing partnerships and collaborations by key market players are expected to generate market growth opportunities. However, lack of awareness about the usage of autoinjectors in developing countries and limited access to healthcare in emerging countries are major challenges in the autoinjectors market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the autoinjectors market are Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), SHL Medical (Switzerland), Recipharm AB (Sweden), Owen Mumford Limited (U.K), Halozyme, Inc. (U.S.), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Israel), Solteam Incorporation Co., Ltd. (China), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Bayer AG (Germany), and Union Medico ApS. (Denmark).
Among all the autoinjector types studied in this report, the smart autoinjectors segment is projected to register the highest CAGR of 9.7% during the forecast period. The high CAGR of the segment is attributed to the benefits of smart autoinjectors, technological advancements in smart autoinjectors, and the rise in digitized drug delivery. Digital drug delivery has shown improved patient outcomes in multiple drug treatments. In May 2021, Phillips-Medisize, LLC (U.S.), a company specializing in drug delivery, diagnostic, and MedTech devices, introduced the Aria Smart Autoinjector platform to unlock innovation, differentiation, and sustainability in the digital drug-delivery device market.
Among all the routes of administration studied in this report, in 2024, the subcutaneous segment is expected to account for a larger share of the autoinjectors market. The segment's larger share can be attributed to the rising number of newly launched drugs for subcutaneous self-administration and the higher adoption due to cost-effectiveness.
Among all the technologies studied in this report, in 2024, the manual autoinjector segment is expected to account for the larger share of the autoinjectors market. The larger market share can be attributed to the high adoption of manual autoinjectors due to their lower prices than automatic autoinjectors and easy accessibility in the distribution channel.
Among all the applications studied in this report, in 2024, the diabetes segment is expected to account for the largest share of the autoinjectors market. The segment's larger share can be attributed to the high burden of diabetes globally coupled with patient inclination towards self-administration of insulin. For instance, according to the Centers for Disease Control and Prevention, as of May 2024, around 38.4 million individuals in the U.S. had diabetes (11.6% of the U.S. population).
Among all the distribution channels studied in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of the autoinjectors market. The segment's large market can be attributed to its easy accessibility to autoinjectors in retail pharmacies. Retail pharmacies enable patients to choose between autoinjectors that best suit their needs as per physician recommendations.
Among all the end users studied in this report, the homecare segment is projected to register the highest CAGR of 8.8% during the forecast period. The segment's fast growth can be attributed to patients' growing preference for self-administration. Technological developments in autoinjectors, such as smart autoinjectors available in the audio and visual feedback system, enable enhanced safety for patients in home care, thereby improving patient outcomes.
An in-depth analysis of the geographical scenario of the autoinjectors market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 8.8% during the forecast period. The fastest growth of the market is due to rising spending on healthcare, advancing healthcare, rising preference for home care, and growing awareness among patients or caretakers regarding self-administration of drugs.
Autoinjectors Market Assessment-by Type
Autoinjectors Market Assessment-by Route of Administration
Autoinjectors Market Assessment-by Technology
Autoinjectors Market Assessment-by End User
Autoinjectors Market Assessment-by Application
(Note: Other applications include epilepsy, oncology, anaphylaxis, migraine, and anemia.)
Autoinjectors Market Assessment-by Distribution Channel
Autoinjectors Market Assessment-by End User
(Note: Other end users include long-term care settings and military & defense)
Autoinjectors Market Assessment-by Geography
(Note: SWOT analysis will be provided for the top 5 companies.)